2008 new Food and Drug Administration (FDA) requirements curtailed the advertising of pancreatic enzyme products (PEPs) by establishing new quality standards because of their use in america; this revision comes at a cost. formulated with mixtures of lipases amylases and proteases. They are accustomed to deal with symptoms of exocrine pancreatic insufficiency caused by cystic… Continue reading 2008 new Food and Drug Administration (FDA) requirements curtailed the advertising